Why Need to Watch : Micron Technology (NASDAQ:MU), Companhia Siderurgica Nacional (NYSE:SID), DARA BioSciences, Inc (NASDAQ:DARA), Citigroup Inc. (NYSE:C), Exxon Mobil (NYSE:XOM)

Azentus Capital Management is one of Hong Kong’s largest hedge funds. Managed by Morgan Sze, the fund had the best returns since inception in 2013. Last quarter, Mr. Sze placed his largest bet on Micron Technology Inc (NASDAQ:MU), which displaced Twenty-First Century Fox Inc (NASDAQ:FOX). The $34.71 billion market cap semiconductor manufacturer saw the fund boost its exposure by 52% over the quarter, to 1.08 … Continue reading Why Need to Watch : Micron Technology (NASDAQ:MU), Companhia Siderurgica Nacional (NYSE:SID), DARA BioSciences, Inc (NASDAQ:DARA), Citigroup Inc. (NYSE:C), Exxon Mobil (NYSE:XOM)

Gainers in news: Fusion-IO, Inc. (NYSE:FIO), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), DARA Biosciences Inc (NASDAQ:DARA), Tesla Motors Inc (NASDAQ:TSLA), TW Telecom Inc (NASDAQ:TWTC)

SanDisk Corp. agreed to buy Fusion-io Inc. (NYSE:FIO) for about $1.1 billion, gaining a provider of storage systems to Facebook Inc. and Apple Inc. and a route to grow its data center business. Fusion-IO, Inc. (NYSE:FIO) stock performance was 22.41% in last session and finished the day at $11.36. Traded volume was 53.52million shares in the last session and the average volume of the stock remained … Continue reading Gainers in news: Fusion-IO, Inc. (NYSE:FIO), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), DARA Biosciences Inc (NASDAQ:DARA), Tesla Motors Inc (NASDAQ:TSLA), TW Telecom Inc (NASDAQ:TWTC)

Gilead Sciences GILD NASDAQ:GILD

Biotech Volatile Stocks: DARA Biosciences Inc (NASDAQ:DARA), Concert Pharmaceuticals Inc (NASDAQ:CNCE), Prosensa Holding NV (NASDAQ:RNA), CytRx Corporation (NASDAQ:CYTR)

DARA Biosciences Inc (NASDAQ:DARA) on May 15 announced its support for Neuropathy Awareness Week which is being observed during the week of May 12, 2014 and sponsored in the U.S. by The Neuropathy Association (www.neuropathy.org). DARA Biosciences Inc (NASDAQ:DARA) stock performance was -26.61% in last session and finished the day at $1.60. Traded volume was 4.15million shares in the last session and the average volume … Continue reading Biotech Volatile Stocks: DARA Biosciences Inc (NASDAQ:DARA), Concert Pharmaceuticals Inc (NASDAQ:CNCE), Prosensa Holding NV (NASDAQ:RNA), CytRx Corporation (NASDAQ:CYTR)

Nano Cap stocks in news: DARA Biosciences (NASDAQ:DARA), RXi Pharmaceuticals Corp (NASDAQ:RXII), Spherix Inc (NASDAQ:SPEX), Biodel Inc (NASDAQ:BIOD)

DARA Biosciences Inc (NASDAQ:DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatment, today announced that Soltamox has been added to the Federal Supply Schedule for purchase by all government agencies. DARA Biosciences Inc (NASDAQ:DARA)stock performance was -4.12% in last … Continue reading Nano Cap stocks in news: DARA Biosciences (NASDAQ:DARA), RXi Pharmaceuticals Corp (NASDAQ:RXII), Spherix Inc (NASDAQ:SPEX), Biodel Inc (NASDAQ:BIOD)

Notable Losers: Kingtone Wirelessinfo Solutions (NASDAQ:KONE), DARA Biosciences (NASDAQ:DARA), Synergy Pharmaceuticals (NASDAQ:SGYPU), Carver Bancorp (NASDAQ:CARV)

Kingtone Wirelessinfo Solution Holding Ltd (NASDAQ:KONE), a China-based developer and provider of mobile enterprise solutions, announced that the Company and its employees received five awards from its wireless system development work for the Company’s largest client, Hualu Engineering & Technology Co., Ltd. (“Hualu”). The awards were issued by Hualu to recognize the excellent work accomplished by Kingtone and its employees. Kingtone Wirelessinfo Solutions Hldg Ltd … Continue reading Notable Losers: Kingtone Wirelessinfo Solutions (NASDAQ:KONE), DARA Biosciences (NASDAQ:DARA), Synergy Pharmaceuticals (NASDAQ:SGYPU), Carver Bancorp (NASDAQ:CARV)

Biotech Gainers: Arrowhead Research (NASDAQ:ARWR), DARA Biosciences (NASDAQ:DARA), Synthetic Biologics (NYSEMKT:SYN), Oncothyreon (NASDAQ:ONTY)

Equities research analysts at Deutsche Bank assumed coverage on shares of Arrowhead Research Corp (NASDAQ:ARWR) in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $45.00 price target on the stock. Arrowhead Research Corp (NASDAQ:ARWR) stock performance was 24.46% in last session and finished the day at $26.31. Traded volume was 7,684,553 million shares in the … Continue reading Biotech Gainers: Arrowhead Research (NASDAQ:ARWR), DARA Biosciences (NASDAQ:DARA), Synthetic Biologics (NYSEMKT:SYN), Oncothyreon (NASDAQ:ONTY)